Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Folic Acid | 7 | 2014 | 57 | 1.610 |
Why?
|
| Homocysteine | 4 | 2014 | 51 | 0.690 |
Why?
|
| Apolipoproteins E | 7 | 2005 | 78 | 0.640 |
Why?
|
| Vitamin E Deficiency | 7 | 2009 | 9 | 0.560 |
Why?
|
| Dietary Supplements | 3 | 2014 | 214 | 0.560 |
Why?
|
| Cognition Disorders | 3 | 2014 | 202 | 0.500 |
Why?
|
| Methionine | 1 | 2014 | 52 | 0.500 |
Why?
|
| Folic Acid Deficiency | 5 | 2009 | 9 | 0.480 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 105 | 0.450 |
Why?
|
| Oxidative Stress | 8 | 2009 | 245 | 0.380 |
Why?
|
| Aging | 2 | 2014 | 683 | 0.360 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2008 | 18 | 0.340 |
Why?
|
| Neural Tube Defects | 1 | 2008 | 25 | 0.330 |
Why?
|
| Selection, Genetic | 1 | 2008 | 69 | 0.320 |
Why?
|
| Autistic Disorder | 1 | 2008 | 154 | 0.280 |
Why?
|
| S-Adenosylmethionine | 3 | 2014 | 26 | 0.270 |
Why?
|
| Vitamin E | 2 | 2003 | 52 | 0.240 |
Why?
|
| Alleles | 1 | 2004 | 400 | 0.230 |
Why?
|
| Antioxidants | 2 | 2003 | 198 | 0.210 |
Why?
|
| Brain | 3 | 2005 | 1193 | 0.210 |
Why?
|
| Pregnancy | 3 | 2014 | 2157 | 0.200 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 3 | 2005 | 15 | 0.140 |
Why?
|
| Acetylcysteine | 2 | 2005 | 17 | 0.130 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 24 | 0.130 |
Why?
|
| Vitamin B Complex | 1 | 2014 | 22 | 0.120 |
Why?
|
| Prenatal Care | 1 | 2014 | 178 | 0.110 |
Why?
|
| Nutritional Status | 1 | 2012 | 119 | 0.100 |
Why?
|
| Mice | 9 | 2012 | 9258 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2005 | 2908 | 0.090 |
Why?
|
| Dementia | 1 | 2012 | 195 | 0.090 |
Why?
|
| Neurons | 2 | 2005 | 755 | 0.090 |
Why?
|
| Apolipoprotein E4 | 1 | 2009 | 27 | 0.090 |
Why?
|
| tau Proteins | 1 | 2009 | 80 | 0.080 |
Why?
|
| Mice, Knockout | 5 | 2005 | 1889 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 171 | 0.080 |
Why?
|
| Female | 3 | 2014 | 26647 | 0.080 |
Why?
|
| Animals | 10 | 2012 | 17885 | 0.080 |
Why?
|
| Nerve Degeneration | 2 | 2004 | 55 | 0.080 |
Why?
|
| Glutathione | 2 | 2004 | 47 | 0.070 |
Why?
|
| Alzheimer Disease | 2 | 2012 | 415 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 1104 | 0.070 |
Why?
|
| Ganglia, Spinal | 1 | 2004 | 20 | 0.060 |
Why?
|
| Tubercidin | 1 | 2004 | 2 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 121 | 0.060 |
Why?
|
| Humans | 5 | 2014 | 50795 | 0.060 |
Why?
|
| Adenine | 1 | 2004 | 39 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2005 | 143 | 0.060 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 55 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2004 | 1779 | 0.060 |
Why?
|
| Iron, Dietary | 1 | 2002 | 9 | 0.060 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2002 | 23 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2004 | 195 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 282 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2003 | 341 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2003 | 94 | 0.050 |
Why?
|
| Calcium | 1 | 2004 | 522 | 0.050 |
Why?
|
| Liver | 1 | 2002 | 708 | 0.040 |
Why?
|
| Male | 1 | 2014 | 23363 | 0.030 |
Why?
|
| Maze Learning | 2 | 2004 | 51 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2005 | 1997 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 789 | 0.020 |
Why?
|
| Diet, Protein-Restricted | 1 | 2005 | 11 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 67 | 0.020 |
Why?
|
| Nimodipine | 1 | 2004 | 2 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 3 | 0.020 |
Why?
|
| Xanthenes | 1 | 2004 | 8 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2004 | 18 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2004 | 49 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2004 | 27 | 0.020 |
Why?
|
| Glutathione Synthase | 1 | 2004 | 1 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 281 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 155 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2004 | 127 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 218 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 156 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2003 | 10 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 180 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2004 | 79 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 371 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1472 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 303 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 459 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 1256 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 551 | 0.010 |
Why?
|